focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,172.00
Bid: 12,168.00
Ask: 12,170.00
Change: -74.00 (-0.60%)
Spread: 2.00 (0.016%)
Open: 12,240.00
High: 12,306.00
Low: 12,132.00
Prev. Close: 12,246.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-British PM Johnson to unveil international travel plan amid COVID-19

Mon, 05th Apr 2021 07:49

* British PM Johnson to set out plans at 1700 local time

* International travel will not start before May 17

* Airlines, hotels hope for a relaunch
(Recasts lead, adds travel quotes)

By Kate Holton

LONDON, April 5 (Reuters) - British Prime Minister Boris
Johnson will unveil a traffic light system to relaunch
international travel on Monday, offering hope for airlines and
European holiday resorts struggling in the COVID-19 pandemic.

Johnson has already announced a staggered plan to ease
coronavirus restrictions in the months ahead. He now wants to
enable international travel to resume without setting back
efforts to curb the spread of COVID-19 in Britain.

At a 5 p.m. (1600 GMT) news conference, he will outline a
system ranking countries as red, amber or green, based on their
levels of infection and vaccination, and on the presence of
coronavirus variants.

Noel Josephides, chairman of travel group Sunvil, said the
industry ideally needed a month to prepare. He hoped any testing
requirements could involve cheaper and rapid tests if customers
were going to be persuaded to book.

"The tour operating and travel agency business cannot go
through another summer of earning nothing. No one's earned
anything for over a year now," he told Reuters.

Britons are among the highest spending tourists in Europe.
Josephides said airlines and hotels were waiting to decide
whether they would resume operations.

British media suggested countries on the green list,
requiring only testing before and after travel, could include
Portugal, Malta, Israel, the United Arab Emirates and the United
States.

Under the plan, international travel would not resume until
May 17 at the earliest. Countries on the amber list would
require self-isolation. Those on the red list would require
quarantine.

Airlines such as easyJet, Ryanair and
British Airways, plus holiday groups such as TUI
, hope to avoid a second lost summer but COVID-19
cases have risen in continental Europe.

Johnson is also widely expected to confirm plans to allow
all retail, outdoor hospitality and hairdressers to open in
England on April 12, with trials of "vaccine passports" taking
place to help relaunch mass events.

The government is offering everyone in England two rapid
tests a week, to break chains of transmission and spot
asymptomatic cases.

"As we continue to make good progress on our vaccine
programme and with our roadmap to cautiously easing restrictions
underway, regular rapid testing is even more important to make
sure those efforts are not wasted," Johnson said in a statement.

Britain has given AstraZeneca and Pfizer
shots to more than half the adult population, and the reopening
of schools in March has so far caused no spike in cases.

(Editing by Jan Harvey, Emelia Sithole-Matarise and Timothy
Heritage)

More News
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit.

Read more
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.